Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Twist Bioscience Corp (NQ: TWST ) 56.05 -2.83 (-4.81%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Twist Bioscience Corp < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > Twist Bioscience Internally-Discovered Single Domain Antibody TB202-3 Shows Potent Binding to Multiple Strains of SARS-CoV-2, Including Alpha, Beta, and Gamma Strains, in Preclinical Studies September 23, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Collaborates with Deep Learning Experts deepCDR on Antibody Library Design September 23, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Continues Commitment to Deliver Synthetic RNA Controls, now to Fight Delta Plus Variants of COVID-19 September 14, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics September 13, 2021 From Twist Bioscience Corporation and Adicet Bio Via Business Wire Twist Bioscience, Boehringer Ingelheim Joins Forces For Antibody Research Programs September 09, 2021 Twist Bioscience Corporation (NASDAQ: TWST) has announced a broad-based research collaboration with Boehringer Ingelheim International GmbH. The collaboration... Via Benzinga Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration September 09, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Present at Baird 2021 Global Healthcare Conference September 08, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience, SomaLogic Team Up For Antibodies, Target Discovery August 18, 2021 Twist Bioscience Corporation (NASDAQ: TWST) and SomaLogic announced a partnership to discover novel therapeutic targets and antibodies. Financial and other... Via Benzinga Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit August 10, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Corporation (TWST) Q3 2021 Earnings Call Transcript August 06, 2021 TWST earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Twist Bioscience Stock Falls On Wider Q3 Loss, Sales Beat Estimates; Raises FY21 Guidance August 06, 2021 Twist Bioscience Corporation (NASDAQ: TWST) reported a 65% Y/Y increase in its third-quarter revenues to $35 million, beating the Wall Street estimate of $32.27 million... Via Benzinga Topics Earnings Exposures Financial Twist Bioscience: Q3 Earnings Insights August 06, 2021 Shares of Twist Bioscience (NASDAQ:TWST) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share were down 22.39% year over year to... Via Benzinga Twist Bioscience Reports Third Quarter Fiscal 2021 Financial Results August 06, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors August 06, 2021 From Twist Bioscience Corporation Via Business Wire The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO August 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... Via Benzinga Earnings Scheduled For August 6, 2021 August 06, 2021 Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million.... Via Benzinga The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs August 01, 2021 Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... Via Benzinga Exposures Product Safety Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery July 26, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests July 22, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021 July 21, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Acquires NGS Library Preparation Maker iGenomX June 30, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening June 14, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Announces Fireside Chat and Presentation at BIO Digital June 14, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Stock Hits 80-Plus Relative Strength Rating Benchmark June 11, 2021 TwistBioscienceCorp shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82. Via Investor's Business Daily DNA Data Storage Alliance Publishes First White Paper, Launches Website June 10, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests June 08, 2021 From Twist Bioscience Corporation Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For June 4, 2021 June 04, 2021 Upgrades According to Argus Research, the prior rating for Diageo PLC (NYSE:DEO) was changed from Hold to Buy. The current stock performance of Diageo shows a 52-week-high... Via Benzinga 2 Top Biotech Picks to Buy and Hold for the Next 10 Years May 29, 2021 Incredible scientific advances could reward investors -- if they have the patience. Via The Motley Fool Twist Bioscience Stock Scores Relative Strength Rating Upgrade May 28, 2021 When adding stocks to your watch list, look for stocks with an 80 or higher RS Rating. Twist Bioscience just met that criteria with a new score of 84. Via Investor's Business Daily Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications May 25, 2021 From Twist Bioscience Corporation Via Business Wire < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.